Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Vasconcelles Michael. Insider active across 2 companies, notably ImmunoGen, Inc.. Cumulatively, 4 disclosures have been logged. Activity tracked since 29 December 2023. The latest transaction was filed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
VASCONCELLES MICHAEL is a declarant linked to Day One Biopharmaceuticals, Inc. and ImmunoGen, Inc., where he serves as Head of Research and Dev. and EVP R&D & MEDICAL AFFAIRS, respectively. He has 4 filings in total, and the recent filings tracked run from 2024-01-03 to 2026-04-23, with a dominant transaction nature indicated as Disposition.